These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9795083)

  • 1. Development of a multiple-drug delivery implant for intraocular management of proliferative vitreoretinopathy.
    Zhou T; Lewis H; Foster RE; Schwendeman SP
    J Control Release; 1998 Nov; 55(2-3):281-95. PubMed ID: 9795083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation and characterization of injectable poly(DL-lactide-co-glycolide) implants loaded with N-acetylcysteine, a MMP inhibitor.
    Desai KG; Mallery SR; Schwendeman SP
    Pharm Res; 2008 Mar; 25(3):586-97. PubMed ID: 17891553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained release of cis-hydroxyproline in the treatment of experimental proliferative vitreoretinopathy in rabbits.
    Yasukawa T; Kimura H; Tabata Y; Miyamoto H; Honda Y; Ogura Y
    Graefes Arch Clin Exp Ophthalmol; 2002 Aug; 240(8):672-8. PubMed ID: 12192462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal sustained release corticosteroid-5-fluoruracil conjugate in the treatment of experimental proliferative vitreoretinopathy.
    Berger AS; Cheng CK; Pearson PA; Ashton P; Crooks PA; Cynkowski T; Cynkowska G; Jaffe GJ
    Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2318-25. PubMed ID: 8843916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An intravitreal sustained-release triamcinolone and 5-fluorouracil codrug in the treatment of experimental proliferative vitreoretinopathy.
    Yang CS; Khawly JA; Hainsworth DP; Chen SN; Ashton P; Guo H; Jaffe GJ
    Arch Ophthalmol; 1998 Jan; 116(1):69-77. PubMed ID: 9445210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and evaluation of a novel biodegradable long-acting intravitreal implant containing ligustrazine for the treatment of proliferative vitreoretinopathy.
    Zhang X; Wei J; Ma P; Mu H; Wang A; Zhang L; Wu Z; Sun K
    J Pharm Pharmacol; 2015 Feb; 67(2):160-9. PubMed ID: 25557298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implantable biodegradable polymeric device in the treatment of experimental proliferative vitreoretinopathy.
    Hashizoe M; Ogura Y; Takanashi T; Kunou N; Honda Y; Ikada Y
    Curr Eye Res; 1995 Jun; 14(6):473-7. PubMed ID: 7671629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of experimental proliferative vitreoretinopathy with a biodegradable intravitreal implant for the sustained release of fluorouracil.
    Rubsamen PE; Davis PA; Hernandez E; O'Grady GE; Cousins SW
    Arch Ophthalmol; 1994 Mar; 112(3):407-13. PubMed ID: 8129669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled release of triamcinolone from an episcleral micro film delivery system for open-globe eye injuries and proliferative vitreoretinopathy.
    Wu S; Bian C; Li X; Chen M; Yang J; Jin Y; Shen Y; Cheng L
    J Control Release; 2021 May; 333():76-90. PubMed ID: 33771623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled release of clot-dissolving tissue-type plasminogen activator from a poly(L-glutamic acid) semi-interpenetrating polymer network hydrogel.
    Park Y; Liang J; Yang Z; Yang VC
    J Control Release; 2001 Jul; 75(1-2):37-44. PubMed ID: 11451495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel design of one-side coated biodegradable intrascleral implant for the sustained release of triamcinolone acetonide.
    Kim YM; Lim JO; Kim HK; Kim SY; Shin JP
    Eur J Pharm Biopharm; 2008 Sep; 70(1):179-86. PubMed ID: 18667297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stabilization of 10-hydroxycamptothecin in poly(lactide-co-glycolide) microsphere delivery vehicles.
    Shenderova A; Burke TG; Schwendeman SP
    Pharm Res; 1997 Oct; 14(10):1406-14. PubMed ID: 9358554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis.
    Duvvuri S; Janoria KG; Pal D; Mitra AK
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):264-74. PubMed ID: 17593010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antiproliferative effect of sustained drug delivery system of all-trans retinoic acid implant into rabbit's vitreous cavity for treatment of proliferative vitreoretinopathy].
    Yan XR; Dong XG; Chen N; Wang W
    Zhonghua Yan Ke Za Zhi; 2003 Oct; 39(10):621-5. PubMed ID: 14766078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivery systems for the treatment of proliferative vitreoretinopathy: materials, devices and colloidal carriers.
    Guidetti B; Azéma J; Malet-Martino M; Martino R
    Curr Drug Deliv; 2008 Jan; 5(1):7-19. PubMed ID: 18220546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro release of fluoropyrimidines from PLGA film implants.
    Dorta MJ; Oliva A; Munguía O; Llabrés M; Fariña JB
    J Pharm Pharmacol; 2002 Jun; 54(6):757-63. PubMed ID: 12078991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An intravitreal biodegradable sustained release naproxen and 5-fluorouracil system for the treatment of experimental post-traumatic proliferative vitreoretinopathy.
    Cardillo JA; Farah ME; Mitre J; Morales PH; Costa RA; Melo LA; Kuppermann B; Jorge R; Ashton P
    Br J Ophthalmol; 2004 Sep; 88(9):1201-5. PubMed ID: 15317716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of Mg(OH)2 and sucrose on the stability of bovine serum albumin encapsulated in injectable poly(D,L-lactide-co-glycolide) implants.
    Kang J; Schwendeman SP
    Biomaterials; 2002 Jan; 23(1):239-45. PubMed ID: 11762843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Episcleral drug film for better-targeted ocular drug delivery and controlled release using multilayered poly-ε-caprolactone (PCL).
    Sun S; Li J; Li X; Lan B; Zhou S; Meng Y; Cheng L
    Acta Biomater; 2016 Jun; 37():143-54. PubMed ID: 27071973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant monitoring of implant formation and drug release of in situ forming poly (lactide-co-glycolide acid) implants in a hydrogel matrix mimicking the subcutis using UV-vis imaging.
    Sun Y; Jensen H; Petersen NJ; Larsen SW; Østergaard J
    J Pharm Biomed Anal; 2018 Feb; 150():95-106. PubMed ID: 29216591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.